Simplify Logo

Full-Time

Associate Director

Regulatory Operations

Posted on 9/6/2024

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology
Healthcare

Senior, Expert

Princeton, NJ, USA

Category
Risk & Compliance
Legal & Compliance
Required Skills
Communications
Management
Quality Assurance (QA)
Requirements
  • Bachelor’s degree in scientific discipline or related field.
  • Targeting 8 years of regulatory operations experience within the pharmaceutical or biotech industry.
  • Must have strong expertise in the eCTD process, oversight of electronic document management systems, and publishing software and tools.
  • Must have technical expertise in EDMS oversight.
  • Thorough knowledge of US and international regulations as they apply to Regulatory Affairs.
  • Ability to influence and partner cross-functionally.
  • Self-organized, self-directing, and highly motivated.
  • Strong critical thinking and analytical skills.
  • Demonstrated ability to contribute to a continuous learning and process improvement environment.
  • Good verbal and written organizational and communication skills.
  • Skilled at negotiating with business partners and influencing management regarding matters of significance.
Responsibilities
  • Support Acadia’s regulatory systems portfolio including Veeva Vault Submissions, IQVIA RIM Smart, and other utilities and tools used in the management of regulatory information and submission production, partnering with IT, and vendors.
  • Support oversight of the business aspects of Vault RIM such as user accounts, project dictionaries, document metadata, and organization.
  • Collaborate with cross-functional team members and external contractors/vendors/consultants to support the planning, preparation, formatting, timely delivery of documents, publishing, QC, submission and archiving of regulatory submissions (i.e., INDs/CTAs/NDAs/MAAs and amendments/supplements, responses to health authority requests for information, health authority briefing documents, etc).
  • Responsible for the development, implementation, and rollout of training to the organization on Regulatory Operations processes and systems, including but not limited to Starting Point Templates, existing processes or systems, the introduction of new processes and/or systems, and the training of new employees as necessary.
  • Offers document management expertise and assists with regulatory submission strategy as needed.
  • Interpret and enforce electronic regulatory submission standards, policies and operating procedure requirements.
  • Serve as a point of escalation for process and technical issues that arise during submission preparation and publishing.
  • Partner with IT and QA on the change management, release management, and ongoing validation of all Regulatory Operation computer systems.
  • Survey current and emerging regulatory guidance’s, best practices, and technology advances to make recommendations for systems and/or process projects and initiatives.
  • Lead development and maintain process and standards documents (e.g., SOPs, work instructions, checklists) related to document/submission publishing and regulatory systems.
  • Other duties as required.
Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. Their products are created through extensive research and development, followed by rigorous clinical trials to ensure safety and effectiveness. Once approved by regulatory bodies like the FDA, these therapies are marketed to patients and healthcare providers. Acadia stands out from competitors by concentrating on areas with significant unmet medical needs and fostering strategic partnerships to enhance their research and market presence. The company's goal is to improve the quality of life for individuals with neurological conditions through effective treatments.

Company Stage

IPO

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's launch of Magnolia's Guide to Adventuring showcases their innovative approach to raising disease awareness and redefining perceptions of Rett syndrome.
  • The acceptance of trofinetide for priority review by Health Canada could lead to significant market expansion and first-mover advantage in treating Rett syndrome in Canada.
  • The appointment of Dr. Elizabeth H. Z. Thompson as Executive Vice President, Head of Research and Development, signals a strong commitment to advancing their R&D capabilities.

What critics are saying

  • The failure of the Phase III ADVANCE-2 trial for pimavanserin in schizophrenia highlights the high-risk nature of drug development in the biopharmaceutical sector.
  • Dependence on regulatory approvals, such as the FDA and Health Canada, introduces uncertainty and potential delays in bringing therapies to market.

What makes Acadia Pharmaceuticals Inc. unique

  • Acadia Pharmaceuticals focuses exclusively on neurological disorders, setting it apart from competitors with broader therapeutic areas.
  • Their commitment to corporate social responsibility, including initiatives like the Rett Sibling Scholarship, enhances their reputation and community engagement.
  • Acadia's strategic partnerships and corporate sponsorships amplify their research capabilities and market reach, distinguishing them from competitors who may not leverage such collaborations.
INACTIVE